COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,283 Articles (22,759 medRxiv, 8,524 bioRxiv)

Most recent first Previous |  Page 2678: Articles 26771-26780  | Next

Covid-19 pandemic and the unprecedented mobilisation of scholarly efforts prompted by a health crisis: Scientometric comparisons across SARS, MERS and 2019-nCov literature
Haghani, M., Bliemer, M. C. J.
10.1101/2020.05.31.126813 — Posted: 2020-06-01
Reconstructing SARS-CoV-2 response signaling and regulatory networks
Ding, J., Lugo-Martinez, J., Yuan, Y., Kotton, D. N., Bar-Joseph, Z.
10.1101/2020.06.01.127589 — Posted: 2020-06-01
Improved and Simplified Diagnosis of Covid-19 using TE Extraction from Dry Swabs
Kiran, U., Gokulan, C. G., Kuncha, S. K., Vedagiri, D., Tallapaka, K. B., Mishra, R. K., Harshan, K.
10.1101/2020.05.31.126342 — Posted: 2020-06-01
A Scalable Topical Vectored Vaccine Candidate Against SARS-CoV-2
Rohaim, M. A., Munir, M.
10.1101/2020.05.31.126524 — Posted: 2020-06-01
coronapp: a Web Application to Annotate and Monitor SARS-CoV-2 Mutations
Mercatelli, D., Triboli, L., Fornasari, E., Ray, F., Giorgi, F. M.
10.1101/2020.05.31.124966 — Posted: 2020-06-01
Minimal system for assembly of SARS-CoV-2 virus like particles
Swann, H., Sharma, A., Preece, B., Peterson, A., Eldredge, C., Belnap, D., Vershinin, M., Saffarian, S.
10.1101/2020.06.01.128058 — Posted: 2020-06-01 Discussion: Offsite
Targeted Intracellular Degradation of SARS-CoV-2 RBD via Computationally-Optimized Peptide Fusions
Chatterjee, P., Ponnapati, M., Jacobson, J. M.
10.1101/2020.06.01.127829 — Posted: 2020-06-01
Synergistic effects of anionic surfactants on coronavirus (SARS-CoV-2) virucidal efficiency of sanitizing fluids to fight COVID-19
Jahromi, R., Mogharab, V., Jahromi, H., Avazpour, A.
10.1101/2020.05.29.124107 — Posted: 2020-06-01
SARS-CoV-2 infection: the environmental endurance of the virus can be influenced by the increase of temperature
Magurano, F., Baggieri, M., Marchi, A., Rezza, G., Nicoletti, L., Covid-19 Study Group
10.1101/2020.05.30.20099143 — Posted: 2020-06-01
Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic
Aznab, M.
10.1101/2020.05.26.20102889 — Posted: 2020-06-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).